Haleon plc
Haleon plc, a leading global consumer healthcare company, is headquartered in Great Britain and operates extensively across Europe, North America, and Asia. Founded in 2022, Haleon emerged from a spin-off of GlaxoSmithKline's consumer healthcare division, marking a significant milestone in the industry. Specialising in over-the-counter medicines, oral health, and wellness products, Haleon offers a diverse portfolio that includes well-known brands such as Sensodyne, Panadol, and Voltaren. These products are distinguished by their commitment to science-backed efficacy and consumer trust. With a strong market position, Haleon is dedicated to improving everyday health and well-being, making it a notable player in the consumer healthcare sector. The company's focus on innovation and sustainability further enhances its reputation as a forward-thinking leader in the industry.
DitchCarbon Score
How does Haleon plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Haleon plc's score of 85 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Haleon plc's reported carbon emissions
In 2024, Haleon plc reported carbon emissions of approximately 2,000,000 kg CO2e for Scope 1 and about 3,000,000 kg CO2e for Scope 2 in Great Britain, totalling around 5,000,000 kg CO2e for both scopes combined. Globally, the company’s emissions were significantly higher, with Scope 1 emissions at about 68,000,000 kg CO2e, Scope 2 at approximately 121,000,000 kg CO2e, and Scope 3 emissions reaching around 2,529,000,000 kg CO2e. Haleon has set ambitious climate commitments, aiming for a 100% reduction in net Scope 1 and 2 emissions by 2030 compared to a 2020 baseline. Additionally, the company targets a 95% reduction in absolute Scope 1 and 2 emissions by 2030. For Scope 3 emissions, Haleon aims to reduce these by approximately 42% by 2030, also using 2022 as a baseline. The company is committed to achieving net zero carbon emissions across all scopes by 2040, aligning with the Climate Pledge and Race to Zero initiatives. These targets reflect Haleon's dedication to sustainability and its proactive approach to addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 59,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 37,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Haleon plc is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
